Canada - English - Health Canada

aa pharma inc - enalapril maleate; hydrochlorothiazide - tablet - 5mg; 12.5mg - enalapril maleate 5mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

aa pharma inc - enalapril maleate; hydrochlorothiazide - tablet - 10mg; 25mg - enalapril maleate 10mg; hydrochlorothiazide 25mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

hikma canada limited - enalaprilat - solution - 1.25mg - enalaprilat 1.25mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

frosst a division of merck canada inc - enalapril sodium; hydrochlorothiazide - tablet - 8mg; 25mg - enalapril sodium 8mg; hydrochlorothiazide 25mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

frosst a division of merck canada inc - enalapril sodium - tablet - 2mg - enalapril sodium 2mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

frosst a division of merck canada inc - enalapril sodium - tablet - 4mg - enalapril sodium 4mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

frosst a division of merck canada inc - enalapril sodium - tablet - 8mg - enalapril sodium 8mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

frosst a division of merck canada inc - enalapril sodium - tablet - 16mg - enalapril sodium 16mg - angiotensin-converting enzyme inhibitors

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - enalapril maleate (unii: 9o25354epj) (enalaprilat anhydrous - unii:q508q118jm) - enalapril maleate 10 mg - enalapril maleate is indicated for the treatment of hypertension. enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of enalapril maleate and thiazides are approximately additive. enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. in these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see clinical pharmacology, heart failure, mortality trials for details and limitations of survival trials). in clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤35 percent), enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure (see clinical pharmacology, heart failure, mor

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - enalapril maleate (unii: 9o25354epj) (enalaprilat anhydrous - unii:q508q118jm) - enalapril maleate 20 mg - enalapril maleate is indicated for the treatment of hypertension. enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of enalapril maleate and thiazides are approximately additive. enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. in these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see clinical pharmacology, heart failure, mortality trials for details and limitations of survival trials). in clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤35 percent), enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure (see clinical pharmacology, heart failure, mortality trials for details and